Refractory or Relapsed Solid Tumors
Also known as: Relapsed or Refractory Solid Tumors
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11945 | Avelumab | 1 | Completed | 1 |
| DB12737 | Brontictuzumab | 1 | Completed | 1 |
| DB01611 | Hydroxychloroquine | 1 | Completed | 1 |
| DB00398 | Sorafenib | 1 | Completed | 1 |
| DB00480 | Lenalidomide | 1 / 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Terminated | 1 |
| DB09078 | Lenvatinib | 2 | Active Not Recruiting | 1 |